Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company’s Pioneering Work in Mitochondrial Medicine Press Release / April 8, 2026June 25, 2026
Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research Press Release / March 23, 2026June 25, 2026
Stealth BioTherapeutics Provides Commercial and R&D Pipeline Update and Outlines 2026 Strategic Priorities Press Release / January 6, 2026August 24, 2026
